285 related articles for article (PubMed ID: 34333685)
1. State of the art in translating experimental myelomeningocele research to the bedside.
Sbragia L; da Costa KM; Nour ALA; Ruano R; Santos MV; Machado HR
Childs Nerv Syst; 2021 Sep; 37(9):2769-2785. PubMed ID: 34333685
[TBL] [Abstract][Full Text] [Related]
2. Contemporary management and outcome of myelomeningocele: the Rotterdam experience.
Spoor JKH; Gadjradj PS; Eggink AJ; DeKoninck PLJ; Lutters B; Scheepe JR; van Meeteren J; de Laat PCJ; van Veelen ML; de Jong THR
Neurosurg Focus; 2019 Oct; 47(4):E3. PubMed ID: 31574477
[TBL] [Abstract][Full Text] [Related]
3. First-time tethered cord release among adults with myelomeningocele: an analysis of people in the National Spina Bifida Patient Registry.
Dias MS; Wang M; Liang M; Rizk EB; Bowman R; Partington MD; Blount JP; Rocque BG; Hopson B; Lee A; Walker WO
J Neurosurg Spine; 2023 Oct; 39(4):527-533. PubMed ID: 37347622
[TBL] [Abstract][Full Text] [Related]
4. What is the Role of Scoliosis Surgery in Adolescents and Adults with Myelomeningocele? A Systematic Review.
Bradko V; Castillo H; Fremion E; Conklin M; Dahl B; Castillo J
Clin Orthop Relat Res; 2022 Apr; 480(4):773-787. PubMed ID: 34939968
[TBL] [Abstract][Full Text] [Related]
5. Hydrocephalus in Spina Bifida.
Blount JP; Maleknia P; Hopson BD; Rocque BG; Oakes WJ
Neurol India; 2021; 69(Supplement):S367-S371. PubMed ID: 35102990
[TBL] [Abstract][Full Text] [Related]
6. Neurosurgery guidelines for the care of people with spina bifida.
Blount JP; Bowman R; Dias MS; Hopson B; Partington MD; Rocque BG
J Pediatr Rehabil Med; 2020; 13(4):467-477. PubMed ID: 33325414
[TBL] [Abstract][Full Text] [Related]
7. Pre and postnatal care characteristics and management features of children born with myelomeningocele in the post-folate fortification era of staple foods in Costa Rica (2004-2022).
Caceres A; Jimenez-Chaverri AL; Alpizar-Quiros PA; Wong-McClure R
Childs Nerv Syst; 2023 Jul; 39(7):1755-1764. PubMed ID: 37129604
[TBL] [Abstract][Full Text] [Related]
8. First 60 fetal in-utero myelomeningocele repairs at Saint Louis Fetal Care Institute in the post-MOMS trial era: hydrocephalus treatment outcomes (endoscopic third ventriculostomy versus ventriculo-peritoneal shunt).
Elbabaa SK; Gildehaus AM; Pierson MJ; Albers JA; Vlastos EJ
Childs Nerv Syst; 2017 Jul; 33(7):1157-1168. PubMed ID: 28470384
[TBL] [Abstract][Full Text] [Related]
9. What has changed in pediatric neurosurgical care in spina bifida? A 30-year UAB/Children's of Alabama observational overview.
Blount JP; Hopson BD; Johnston JM; Rocque BG; Rozzelle CJ; Oakes JW
Childs Nerv Syst; 2023 Jul; 39(7):1791-1804. PubMed ID: 37233768
[TBL] [Abstract][Full Text] [Related]
10. Severe and progressive neuronal loss in myelomeningocele begins before 16 weeks of pregnancy.
Ben Miled S; Loeuillet L; Duong Van Huyen JP; Bessières B; Sekour A; Leroy B; Tantau J; Adle-Biassette H; Salhi H; Bonnière-Darcy M; Tessier A; Martinovic J; Causeret F; Bruneau J; Saillour Y; James S; Ville Y; Attie-Bitach T; Encha-Razavi F; Stirnemann J
Am J Obstet Gynecol; 2020 Aug; 223(2):256.e1-256.e9. PubMed ID: 32283072
[TBL] [Abstract][Full Text] [Related]
11. [The significance of associated malformations of the central nervous system in myelomeningocele].
Christensen B; Rand-Hendriksen S
Tidsskr Nor Laegeforen; 1998 Nov; 118(27):4232-4. PubMed ID: 9857808
[TBL] [Abstract][Full Text] [Related]
12. [Maternal-fetal surgery for spina bifida: future perspectives].
Joyeux L; Chalouhi GE; Ville Y; Sapin E
J Gynecol Obstet Biol Reprod (Paris); 2014 Jun; 43(6):443-54. PubMed ID: 24582882
[TBL] [Abstract][Full Text] [Related]
13. Spina bifida and other neural tube defects.
Northrup H; Volcik KA
Curr Probl Pediatr; 2000; 30(10):313-32. PubMed ID: 11147289
[TBL] [Abstract][Full Text] [Related]
14. Reviewing the prognostic factors in myelomeningocele.
Protzenko T; Bellas A; Pousa MS; Protzenko M; Fontes JM; de Lima Silveira AM; Sá CA; Pereira JP; Salomão RM; Salomão JFM; Dos Santos Gomes SC
Neurosurg Focus; 2019 Oct; 47(4):E2. PubMed ID: 31574474
[TBL] [Abstract][Full Text] [Related]
15. Trends in incidence and long-term outcomes of myelomeningocele in British Columbia.
North T; Cheong A; Steinbok P; Radic JA
Childs Nerv Syst; 2018 Apr; 34(4):717-724. PubMed ID: 29236131
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid induced myelomeningocele in fetal rats: characterization by histopathological analysis and magnetic resonance imaging.
Danzer E; Schwarz U; Wehrli S; Radu A; Adzick NS; Flake AW
Exp Neurol; 2005 Aug; 194(2):467-75. PubMed ID: 15893307
[TBL] [Abstract][Full Text] [Related]
17. [Prenatal myelomeningocele repair - a chance to improve the quality of life].
Pastuszka A; Bohosiewicz J; Olejek A; Zamłyński J; Horzelska E; Koszutski T
Wiad Lek; 2019; 72(7):1380-1386. PubMed ID: 31398173
[TBL] [Abstract][Full Text] [Related]
18. Trans-amniotic stem cell therapy (TRASCET) minimizes Chiari-II malformation in experimental spina bifida.
Dionigi B; Brazzo JA; Ahmed A; Feng C; Wu Y; Zurakowski D; Fauza DO
J Pediatr Surg; 2015 Jun; 50(6):1037-41. PubMed ID: 25929798
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Prenatal and Postnatal Management of Patients with Myelomeningocele.
Cavalheiro S; da Costa MDS; Moron AF; Leonard J
Neurosurg Clin N Am; 2017 Jul; 28(3):439-448. PubMed ID: 28600017
[TBL] [Abstract][Full Text] [Related]
20. Arnold-Chiari in a fetal rat model of dysraphism.
Weber Guimarães Barreto M; Ferro MM; Guimarães Bittencourt D; Violin Pereira LA; Barini R; Sbragia L
Fetal Diagn Ther; 2005; 20(5):437-41. PubMed ID: 16113568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]